Menopause

Menopause case 2 - Angie

Case 2 Angie

52 year old patient complains of erratic periods and multiple daytime hot flushes. She is struggling at work as laboratory technician because of “brain fog” and is concerned she is developing dementia. Patient came in wanting a blood test and hormone replacement therapy to stop developing dementia.

 

Learning Objectives:

 

  • Indications of blood tests in patients undergoing menopause
  • Prevalence of "brain fog" in menopause
  • How to counsel patients about starting hormone replacement therapy and its risks

 

Duration | 9 minutes 01 seconds

 

Menopause Case 2 - Angie

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Speakers

Dr Diana Mansour

 

Consultant in Community Gynaecology and Reproductive Health Care, FSRH Senior Vice President. New Croft Centre, Newcastle upon Tyne, United Kingdom.

Dr Diana Mansour

Dr Diana Mansour is a Consultant in Community Gynaecology and Reproductive Health Care and Associate Clinical Lecturer at the University of Newcastle since 1997. In addition Dr Mansour is the Senior Vice President for the Faculty of Sexual and Reproductive Healthcare.

 

Dr Mansour was the first accredited subspecialty trainee in Community Gynaecology and Reproductive Health Care of the Royal College of Obstetricians and Gynaecologists. Dr Mansour is first author to over 90 peer-reviewed publications and has most recently published in Contraception and the BMJ SRH.

 

Dr Mansour’s areas of expertise include acceptability of contraceptive methods, non-contraceptive benefits of contraception, development of long-term methods of contraception, changes in health service provision, medical management of menstrual disorders and management of the menopause.

 

Dr Sarah Gray

 

Dr Sarah Gray

Sarah Gray has spent over 30 years delivering Women’s Health in Primary Care. She is a GP in Cornwall and ran their menopause referral clinic for 15 years until decommissioned in 2016. She still works within the NHS. However, she provides most of her specialist menopause advice from the independent sector.

 

Sarah is considered a national opinion leader. She sat on the British Menopause Society Council for 10 years and was a member of the groups who developed NICE CG44 (updated and replaced with NG88) and Quality Standards for Heavy Menstrual Bleeding. She is an executive director of the Primary Care Women’s Health Forum and a Training Program Director for the FSRH. She has worked for the GMC and looks for competency assessment as the outcome of training. Sarah provides clinical governance to the public health arm of Cornwall Council. Her latest (international) textbook chapter was published in July 2020.

 

NICE guideline [NG88] Heavy menstrual bleeding: assessment and management Published: March 2018 (Last updated: May 2021) Available at: https://www.nice.org.uk/guidance/ng88/resources/heavy-menstrual-bleeding-assessment-and-management-pdf-1837701412549

NICE Quality standard [QS47] Heavy menstrual bleeding Published: September 2013 (Last updated: October 2020) Available at: https://www.nice.org.uk/guidance/qs47/resources/heavy-menstrual-bleeding-pdf-2098671748549

 

Dr Julie Oliver

 

Dr Julie Oliver

Julie Oliver works part time as a GP in Durham, she is a LARC trainer and educator and is commissioned to provide a community gynaecology service.

 

She has worked for different educational providers at local and national level teaching all aspects of womens health related to primary care. She is the Clinical Director of the Primary Care Women's Health Forum and runs her own business "Durham Gynae". When she isn't working she loves watching gymnastics and athletics.

 

Reporting adverse events and quality complaints

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.

 

If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 011820‍63500 or email: pvuk@bayer.com

 

Further information is available on the “contact” tab at www.bayer.co.uk.